Search
for
Sort by
Research 31–60 of 1000+
- Small Molecule Treatments Improve Differentiation Potential of Human Amniotic Fluid Stem Cells
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Bioactive Small Molecule Enhances Skin Burn Wound Healing and Hair Follicle Regeneration by Activating PI3K/AKT Signaling Pathway: A Preclinical Evaluation in Animal Model
- High-Throughput Screening for Discovering Small Molecules Capable of Increasing the Wnt/β-Catenin Signaling Pathway to Promote Hair and Nail Growth
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Sustained release of inhibitor from bionic scaffolds for wound healing and functional regeneration
- Inhibition of Wnt/β‐catenin pathway promotes regenerative repair of cutaneous and cartilage injury
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Alopecia Areata
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Inhibiting the cytosolic function of CXXC5 accelerates diabetic wound healing by enhancing angiogenesis and skin repair
- ARTS, an unusual septin, regulates tumorigenesis by promoting apoptosis
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Colon Cancer Stem Cells: Promise of Targeted Therapy